首页> 外文会议>International Congress on Neuropathic Pain >Evaluation of the anti-hyperalgesic and anti-allodynic effects of cathepsin S inhibition in a murine model of neuropathic pain
【24h】

Evaluation of the anti-hyperalgesic and anti-allodynic effects of cathepsin S inhibition in a murine model of neuropathic pain

机译:抗痛觉过敏和抗恶性对神经病疼痛小鼠模型中的抗痛觉痛经和抗恶性分解效应

获取原文

摘要

Cathepsin S has been identified as a potential target for therapeutic intervention in the treatment of neuropathic pain. Preclinical testing of cathepsin S inhibitors in rat models of neuropathic pain is complicated due to sequence heterogeneity both within and between different rat strains. To circumvent this issue we sought to validate a murine model of neuropathic pain. This study examined the effects of LHVS a known irreversible inhibitor of both mouse and human cathepsin S protease activity in a murine photochemically-induced partial sciatic nerve injury model. LHVS had anti-allodynic and anti-nociceptive effects on all the tests involving the partially denervated hindpaw, including mechanical, cold and radiant heat stimuli and on the tail flick test. These effects were comparable to that of morphine. This neuropathic pain model represents a suitable preclinical model for evaluating the anti-allodynic and anti-hyperalgesic effects of cathepsin S inhibitors during the drug development process.
机译:组织蛋白酶已被鉴定为治疗神经病疼痛治疗干预的潜在目标。由于不同大鼠菌株内部和之间的序列异质性,在神经病疼痛大鼠模型中对大鼠抑制剂的临床前试验。为了规避这个问题,我们试图验证神经性疼痛的小鼠模型。该研究检测了LHV在小鼠光学诱导的部分坐骨神经损伤模型中的鼠鼠和人组织蛋白酶蛋白酶活性的已知不可逆抑制剂的影响。 LHVs对涉及部分神经保护的后爪的所有测试具有抗体和抗伤害影响,包括机械,冷和辐射热刺激和尾部轻弹试验。这些效果与吗啡的效果相当。这种神经性疼痛模型代表了在药物开发过程中评价组织蛋白酶抑制剂的抗异点和抗痛觉效果的合适临床前模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号